ORCID as entered in ROS
https://orcid.org/0000-0002-0011-3924
Select Publications
Conference Papers
, 2026, 'COMPARISON OF THE EFFICACY AND GUT MICROBIOTA IMPACT OF VONOPRAZAN-BASED VERSUS LANSOPRAZOLE-BASED REGIMENS FOR FIRST-LINE HELICOBACTER PYLORI TREATMENT: A MULTICENTER OPEN-LABEL RANDOMIZED CONTROLLED TRIAL', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, IL, Chicago, pp. S2521 - S2521, presented at
, 2026, 'IDENTIFICATION OF THE OPTIMAL SCREENING STRATEGY FOR HELICOBACTER PYLORI INFECTION FOR GASTRIC CANCER PREVENTION: A MULTICENTER RANDOMIZED CONTROLLED TRIAL', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, IL, Chicago, presented at
, 2026, 'METABOLIC SYNDROME AND BODY COMPOSITION DISPLAY SEX-SPECIFIC EFFECTS ON AIRWAY INFLAMMATION AND CLINICAL ASTHMA OUTCOMES', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 6 - 7
, 2025, 'Case-control study on oral microbiome in females with RRMS', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Brisbane, presented at
, 2025, 'DISTINCT COMPOSITIONS OF GUT MICROBIOTA IN SUBJECTS WITH UNDERWEIGHT, NORMAL BODY MASS INDEX, OVERWEIGHT, AND OBESITY IN THE EAST-ASIAN POPULATION', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, CA, San Diego, presented at
, 2025, 'IMPACT OF THE GUT MICROBIOTA ON IMMUNE MODULATION AND RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN HEPATOCELLULAR CARCINOMA: INSIGHTS FROM HUMAN AND PRECLINICAL MODELS', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, CA, San Diego, presented at
, 2025, 'LOWER DIVERSITY AND DISTINCT COMPOSITIONS OF GUT MICROBIOTA IN PATIENTS WITH HEPATOCELLULAR CARCINOMA', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, CA, San Diego, presented at
, 2025, 'MULTI-OMICS, MULTI-COHORT PROFILING OF THE SMALL BOWEL VERSUS FECAL MYCOBIOME IN CROHN'S DISEASE UNVEILS MUCOSA-ASSOCIATED FUNGUS CLADOSPORIUM SPHAEROSPERMUM COUNTERACTING INTESTINAL INFLAMMATION VIA AMP SYNTHESIS', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, CA, San Diego, presented at
, 2025, 'THE INFLUENCE OF SUPPLEMENTARY PROBIOTICS ON THE ADVERSE EVENTS AND FECAL DYSBIOSIS OF HELICOBACTER PYLORI ERADICATION-A DOUBLE BLIND, MULTI-CENTER RANDOMIZED, PLACEBO-CONTROLLED TRIAL', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, CA, San Diego, presented at
, 2025, 'COMPARISON OF VONOPRAZAN-BASED VERSUS LANSOPRAZOLE-BASED REGIMENS IN THE FIRST-LINE TREATMENT OF HELICOBACTER PYLORI INFECTION-AN INTERIM ANALYSIS OF A MULTICENTER, OPEN-LABELLED, RANDOMIZED CONTROLLED TRIAL', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC
, 2025, 'IDENTIFICATION OF THE OPTIMAL SCREENING STRATEGY FOR HELICOBACTER PYLORI INFECTION: AN INTERIM ANALYSIS OF A MULTICENTER, RANDOMIZED CONTROLLED TRIAL', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC
, 2024, 'COMPARISON OF EMPIRICAL THERAPY VERSUS SUSCEPTIBILITY TESTING-GUIDED THERAPY FOR REFRACTORY HELICOBACTER PYLORI INFECTION: A MULTICENTER, OPEN-LABEL, RANDOMIZED CONTROLLED, NON-INFERIORY TRIAL', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S291 - S291, presented at
, 2024, 'Traditional Asian Diet Benefits on Gut Microbiome, Stool and Urine Metabolomes in Healthy Asian Women', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 113 - 113
, 2023, ' Modulating the gut microbiota alters the gut-liver immune environment in a preclinical model of HCC', in GUT, BMJ PUBLISHING GROUP, PEOPLES R CHINA, Hong Kong, pp. A16 - A16, presented at
, 2023, 'IMPLICATIONS OF ORO-PHARYNGEAL DYSBIOSIS IN HEAD AND NECK CANCER: ORAL MICROBIOME AND CHEMORADIATION-RELATED COMPLICATIONS', in GUT, BMJ PUBLISHING GROUP, PEOPLES R CHINA, Hong Kong, pp. A114 - A116, presented at
, 2023, 'GENOTYPIC RESISTANCE GUIDED THERAPY VERSUS SUSCEPTIBILITY TESTING GUIDED THERAPY IN THE FIRST-LINE AND THIRD-LINE TREATMENT OF HELICOBACTER PYLORI INFECTION-TWO MULTICENTER RANDOMIZED CONTROLLED TRIALS', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, IL, Chicago, pp. S46 - S47, presented at
, 2023, 'Restoring the Capability of Flavonoid Degrading in Gut Alleviates Polycystic Ovary Syndrome (PCOS)', in REPRODUCTIVE SCIENCES, SPRINGER HEIDELBERG, AUSTRALIA, Brisbane, pp. 251A - 251A, presented at
, 2023, 'Determinants of short-chain fatty acid composition in inflammatory bowel disease: Analysis of the AIM cohort', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 196 - 198
, 2023, 'Modulating the gut microbiota alters the gut-liver immune environment in a preclinical model of hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 39 - 39
, 2023, 'Premorbid factors predicting inflammatory bowel disease development in Australia: Analysis of the AIM cohort', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 195 - 196
, 2022, 'THE SHORT-TERM AND LONG-TERM IMPACTS OF H. PYLORI ERADICATION ON THE ANTIBIOTIC RESISTANCE AND RESISTOME OF GUT MICROBIOTA- A MULTICENTER RANDOMIZED TRIAL', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. S212 - S212
, 2019, 'GUT MICROBIOTA MODULATES THE CHEMOPREVENTIVE EFFICACY OF ASPIRIN ON COLORECTAL CANCER THROUGH IMPACT ON ASPIRIN BIOAVAILABILITY', in GUT, BMJ PUBLISHING GROUP, HONG KONG, Hong Kong, pp. A19 - A20, presented at
, 2019, 'LONG-TERM CHANGES OF GUT MICROBIOTA, ANTIBIOTIC RESISTANCE, AND METABOLIC PARAMETERS AFTER HELICOBACTER PYLORI ERADICATION-A MULTICENTRE RANDOMISED TRIAL', in GUT, BMJ PUBLISHING GROUP, HONG KONG, Hong Kong, pp. A5 - A6, presented at
, 2019, 'GUT MICROBIOTA MODULATES THE CHEMOPREVENTIVE EFFICACY OF ASPIRIN ON COLON CANCER THROUGH REDUCING ASPIRIN BIOAVAILABILITY', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, CA, San Diego, pp. S133 - S133, presented at
, 2019, 'LONG-TERM CHANGES OF GUT MICROBIOTA, ANTIBIOTIC RESISTANCE, AND METABOLIC PARAMETERS AFTER HELICOBACTER PYLORI ERADICATION WITH TRIPLE, CONCOMITANT, AND BISMUTH QUADRUPLE THERAPIES - A MULTICENTER RANDOMIZED TRIAL', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, CA, San Diego, pp. S172 - S172, presented at
, 2018, 'Efficacies of genotypic resistance-guided versus empirical therapy for refractory Helicobacter pylori infection: A randomized controlled trial', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 80 - 80, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000450260400094&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2018, 'FECAL MICROBIOTA TRANSPLANTATION CONFERS BENEFICIAL METABOLIC EFFECTS OF DIET AND EXERCISE ON DIET-INDUCED OBESE MICE', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S646 - S646, presented at
, 2017, 'ELUCIDATING THE PATHOGENIC POTENTIAL OF THE INTESTINAL PATHOGEN CAMPYLOBACTER SHOWAE', in GUT, BMJ PUBLISHING GROUP, ENGLAND, Manchester, pp. A138 - A138, presented at
, 2016, 'Transporters for Antiretroviral Drugs in Colorectal CD4+T Cells and Circulating alpha 4 beta 7 Integrin CD4+T Cells: Implications for HIV Microbicides', in AIDS RESEARCH AND HUMAN RETROVIRUSES, MARY ANN LIEBERT, INC, IL, Chicago, pp. 353 - 353, presented at
, 2016, 'Toll-like receptor 8 polymorphisms in Helicobacter pylori infection', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, pp. 637 - 637, presented at
, 2016, 'CYTOPLASMIC EXPRESSION OF HMGB1 IS ASSOCIATED WITH EARLY COLORECTAL CARCINOGENESIS', in GUT, BMJ PUBLISHING GROUP, pp. A192 - A192, http://dx.doi.org/10.1136/gutjnl-2016-312388.354
, 2016, '10-day concomitant therapy, 10-day bismuth quadruple therapy, and 14-day triple therapy in the first-line treatment of Helicobacter pylori infection - a multicenter randomized trial', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 49 - 49
, 2014, 'Characterisation of Drug Transporter Gene Expression in Colorectal Tissue and Cell Lines: Induction with Anti-retrovirals for Microbicide Optimization', in AIDS RESEARCH AND HUMAN RETROVIRUSES, MARY ANN LIEBERT, INC, SOUTH AFRICA, Cape Town, pp. A201 - A201, presented at
, 2014, 'GENOME-WIDE EPIGENETIC ANALYSIS IN CHILDHOOD-ONSET CROHN'S DISEASE IMPLICATES MIR21', in GUT, BMJ PUBLISHING GROUP, ENGLAND, Manchester, pp. A2 - A2, presented at
, 2014, 'Genome-Wide Analysis of DNA Methylation in Low-Grade Colorectal Adenomas and Normal Colonic Mucosa', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, IL, Chicago, pp. S165 - S165, presented at
, 2013, 'ASSESSMENT OF BACTERIAL DIVERSITY IN COLORECTAL ADENOMATOUS POLYPS', in GUT, BMJ PUBLISHING GROUP, SCOTLAND, Glasgow, pp. A134 - A135, presented at
, 2013, 'DEVELOPMENT AND INITIAL VALIDATION OF PROGNOSTIC SCORING SYSTEMS FOR LOWER GASTROINTESTINAL BLEEDING', in GUT, BMJ PUBLISHING GROUP, SCOTLAND, Glasgow, pp. A57 - A57, presented at
, 2013, 'EVALUATION OF FAECAL ASPIRATE AS A PROXY FOR COLONOSCOPY BIOPSY SAMPLING TO ASSESS MICROBIAL DIVERSITY', in GUT, BMJ PUBLISHING GROUP, SCOTLAND, Glasgow, pp. A135 - A135, presented at
, 2013, 'THE MICROAEROPHILIC MICROBIOTA OF DE-NOVO PAEDIATRIC INFLAMMATORY BOWEL DISEASE: THE BISCUIT STUDY', in GUT, BMJ PUBLISHING GROUP, SCOTLAND, Glasgow, pp. A31 - A31, presented at
, 2013, 'THE ROLE OF THE FUNGAL MICROBIOTA IN THE PATHOGENESIS OF DE-NOVO PAEDIATRIC INFLAMMATORY BOWEL DISEASE USING NEXT GENERATION SEQUENCING', in GUT, BMJ PUBLISHING GROUP, SCOTLAND, Glasgow, pp. A32 - A32, presented at
, 2013, 'Assessment of Bacterial Diversity in Colorectal Adenomatous Polyps', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, FL, Orlando, pp. S348 - S348, presented at
, 2013, 'Evaluation of Fecal Aspirate As a Proxy for Colonoscopy Biopsy Sampling to Assess Microbial Diversity', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, FL, Orlando, pp. S832 - S832, presented at
, 2013, 'The Role of the Fungal Microbiota in the Pathogenesis of De-Novo Pediatric Inflammatory Bowel Disease Using Next Generation Sequencing', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, FL, Orlando, pp. S826 - S826, presented at
, 2012, 'Genetic Variation in C20orf54, PLCE1 and MUC1 and Risk of Upper Gastrointestinal Cancers in Caucasian Populations', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, CA, San Diego, pp. S634 - S634, presented at
, 2012, 'Management of Helicobacter pylori infection - The Maastricht IV/ Florence consensus report', in Gut, pp. 646 - 664, http://dx.doi.org/10.1136/gutjnl-2012-302084
, 2011, 'Bacterial Diversity of the Colonic Microbiota in De-Novo Extensive Paediatric Ulcerative Colitis by Next-Generation Sequencing', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, IL, Chicago, pp. S196 - S196, presented at
, 2011, 'Bilirubin Has Anti-Bacterial Properties Against Gram-Positive Bacteria: A Potential Benefit of Physiological Jaundice?', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, IL, Chicago, pp. S941 - S941, presented at
, 2011, 'Detection of Campylobacter Concisus in Colonic Biopsies From Adult Patients With Ulcerative Colitis', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, IL, Chicago, pp. S268 - S268, presented at
, 2011, 'THE ROLE OF MICROAEROPHILIC COLONIC MUCOSAL BACTERIA IN DE NOVO PAEDIATRIC INFLAMMATORY BOWEL DISEASE', in GUT, B M J PUBLISHING GROUP, ENGLAND, Birmingham, pp. A147 - A147, presented at
, 2011, 'COLONIC MUCOSAL BACTERIAL DIVERSITY OF DE NOVO EXTENSIVE PAEDIATRIC ULCERATIVE COLITIS BY NEXT-GENERATION SEQUENCING', in GUT, B M J PUBLISHING GROUP, ENGLAND, Birmingham, presented at
Filter by type
https://orcid.org/0000-0002-0011-3924